Digital Health Market
Oct 13, 2025
Digital Twins in the Healthcare Industry
Digital twins are advanced digital replicas of physical systems, processes, or entities that use real-time data, artificial intelligence (AI), machine learning (ML), and the Internet of Things (IoT) to simulate, monitor, and predict the behavior of their real-world counterparts. In healthcare, digital twins can rep...
Read More...
Oct 10, 2024
Johnson & Johnson Acquires V-Wave; CalmiGo Launches Anxiety-Management Platform CalmiGo Plus; Vy Spine Secures FDA Clearance for 3D-Printed Lumbar IBF; InspireMD Receives IDE Approval for CGuard Stent Study; GE Healthcare Reveals Phase I MRI Contrast Results; Medinol Completes First Human Implantation of Drug-Eluting Stent
Johnson & Johnson Completed Acquisition of V-Wave On Oct 09, 2024, Johnson & Johnson announced that it successfully completed the acquisition of V-Wave Ltd., a privately-held company dedicated to developing innovative treatments for heart failure patients. V-Wave will now operate under Johnson & John...
Read More...
Feb 22, 2024
Johnson & Johnson’s Tecnis PureSee lens; Sparrow BioAcoustics’s Stethoscope Software; Better Therapeutics’s MASH Treatment; X-trodes’ Wearable “Skin” Solution; Lumicell’s LUMISIGHTTM; Konesksa Enrolled First Patient in Learns Observational Study
Johnson & Johnson, Launched New Intraocular Lens in EMEA Region On February 15, 2024, Johnson & Johnson Medtech’s vision unit launched the Tecnis PureSee lens in the EMEA region. Tecnis PureSee is a purely refractive intraocular lens (IOL) specifically designed to correct presbyopia. Its proprietary desi...
Read More...
Nov 23, 2023
Ethicon’s ETHIZIA Hemostatic Sealing Patch; FDA Approves Medtronic’s Minimally Invasive Device to Treat Hypertension; Boston Scientific Acquires Relievant Medsystems; AstraZeneca Launched Evinova; Surmodics Announced Data of the SWING Trial; GSK Advancing the Low Carbon Ventolin Program to Phase III Trials
Ethicon Announced European Approval and Introduction of ETHIZIA™ Hemostatic Sealing Patch Used to Stop Disruptive Bleeding On November 15, 2023, Ethicon, a Johnson & Johnson MedTech company, received approval for ETHIZIA™, an adjunctive hemostat solution that has been clinically proven to achieve sustained h...
Read More...
Jul 27, 2023
VARON’s New VP Series Portable Oxygen Concentrator; Biostrap’s Wrist-Worn Digital Health Monitoring Device; MediView’s AR Navigation Platform; Beckman Coulter’s DxC 500 AU Chemistry Analyzer; Magnus Updated on Study Using SAINT Neuromodulation System; Francis Medical’s VAPOR 2 Pivotal Study
VARON Launched the Game-changer in the Field--New VP Series Portable Oxygen Concentrator On July 19, 2023, VARON, a leading oxygen concentrator manufacturer, announced the launch of a game-changer portable oxygen concentrator VP-2. A new member of the VP series, VP-2 is incorporated with innovative tech...
Read More...
Jul 20, 2023
Relievant Medsystems Launched Ablation System; Thermo Fisher’s Reproductive Health Assays; EarliTec’s Next-Generation EarliPoint Evaluation for ASD; FDA Cleared ReddyPort® Non-Invasive Ventilation Device; EndoTheia’s Novel Medical Device for Endoscopic Surgery; Neurolief’s MOOD Trial Interim Analysis
Relievant Medsystems Launched New Tools for its Ablation System On June 14, 2023, Relievant Medsystems announced that it launched its next-generation access instruments for the Intracept procedure. Chronic vertebrogenic low back pain is treated with Intracept, a minimally invasive, same-day, outpatient proced...
Read More...
Jan 11, 2023
Digital Health: Insights Into the Key Transformative Trends & Evolving Market Dynamics
Over the past few years, the digital health market has registered immense growth owing to technological advancements and rising demand from the consumer side for better health outcomes. As per the latest assessment by DelveInsight, owing to several favorable factors, the global digital health market is estimated to...
Read More...
Nov 24, 2022
Mainstay Medical’s ReActiv8-C Study; Swing Therapeutics Announced Results from Studies of Stanza; FDA Approves Empatica’s Health Monitoring Platform; FDA Clearance to Persona OsseoTi Keel Tibia System; ClariPi Joins Siemens Healthineers Digital Marketplace; Sony Launches Cloud-based Solution for Flow Cytometry Data Analysis
Mainstay Medical Published Post-Market Clinical Trial Data from Ongoing ReActiv8®-C Study On November 22, 2022, Mainstay Medical, a medical devices company, announced that the data from the ReActiv8®-C study, a single-centre, real-world study with a one-year clinical follow-up of selected patients, is publ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
